{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:27:57Z","timestamp":1791408477146,"version":"4.3.3"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            The purpose of the Benestent-II Pilot Study was to evaluate the safety of delaying and eliminating anticoagulant therapy in patients receiving a heparin-coated stent in conjunction with antiplatelet drugs.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            The study consisted of three initial phases (I, II, III) during which resumption of heparin therapy after sheath removal was progressively deferred by 6, 12, and 36 hours. In phase IV, coumadin and heparin were replaced by 250 mg ticlopidine and 100 mg aspirin. Of the 207 patients with stable angina pectoris and a de novo lesion in whom heparin-coated stent implantation was attempted, implantation was successful in 202 patients (98%). Stent thrombosis did not occur during all four phases, and the overall clinical success rate at discharge was 99%. Bleeding complications requiring blood transfusion or surgery fell from 7.9% in phase I to 5.9%, 4%, and 0% in the three following phases. Hospital stay was 7.4, 6.1, 7.2, and 3.1 days for the consecutive phases. The restenosis rate for the combined four phases was 13% (15% in phase I, 20% in phase II, 11% in phase III, and 6% in phase IV). The overall rate of reintervention for the four phases was 8.9%. At 6 months, 84%, 75%, 94%, and 92% of the patients of phases I to IV, respectively, were event free. For the four phases, the event-free rate was 86%, which compares favorably with the rate observed in the Benestent-I study (80%; relative risk, 0.68 [0.45 to 1.04]).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            The implantation of stents coated with polyamine and end-point\u2013attached heparin in stable patients with one significant de novo coronary lesion is well tolerated, is associated with no (sub)acute stent thrombosis, and results in a favorable event-free survival after 6 months.\n          <\/jats:p>","DOI":"10.1161\/01.cir.93.3.412","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"412-422","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":307,"title":["Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries"],"prefix":"10.1161","volume":"93","author":[{"given":"Patrick W.","family":"Serruys","sequence":"first","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha\u030akan","family":"Emanuelsson","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van der Giessen","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Lunn","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Kiemeney","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rutsch","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Heyndrickx","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Legrand","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Jacques","family":"Goy","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Materne","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Bonnier","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Morice","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Fajadet","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Belardi","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulogio","family":"Garcia","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ruygrok","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Jaegere","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange\u0300le","family":"Morel","sequence":"additional","affiliation":[{"name":"From the Thoraxcenter, Department of Interventional Cardiology, Erasmus University, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a059570"},{"key":"e_1_3_1_2_2","first-page":"143B","volume":"17","year":"1991","unstructured":"Serruys PW, Strauss BH, Van Beusekom HMM, van der Giessen WJ. Stenting of coronary arteries: has a modern Pandora\u2019s box been opened? J Am Coll Cardiol. 1991;17:143B-154B.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408253310801"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.6.1891"},{"key":"e_1_3_1_5_2","unstructured":"Bailey SR Paige S Lunn AC Palmaz J. Heparin coating of endovascular stents decreases subacute thrombosis in a rabbit model. Circulation. 1992;86(suppl I):I-186. Abstract."},{"key":"e_1_3_1_6_2","unstructured":"Stratienko AA Zhu D Lambert CR Palmaz J Schatz RA Santamore WP. Improved thromboresistance of heparin-coated Palmaz-Schatz coronary stents in an animal model. Circulation. 1993;88(Pt 2):I-596. Abstract."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.1994.tb00500.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.93.3.423"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.21.6.1160"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-197201000-00003"},{"key":"e_1_3_1_11_2","unstructured":"Larm O Larsson R Olsson P. Surface-immobilized heparin. In: Lane DA Lindahl U eds. Heparin: Chemical and Biological Properties Clinical Applications. London UK: Edward Arnold Press; 1989;99:597-608."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Serruys PW Foley DP De Feyter PJ eds. Quantitative Coronary Angiography in Clinical Practice. Dordrecht the Netherlands: Kluwer Academic; 1994.","DOI":"10.1007\/978-94-015-8358-9"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.2307\/2530643"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Hastings GW ed. Cardiovascular Biomaterials. London UK: Springer-Verlag; 1992.","DOI":"10.1007\/978-1-4471-1847-3"},{"key":"e_1_3_1_15_2","unstructured":"Eloy R Belleville J. Biomaterial-blood interaction. In: Williams D ed. Concise Encyclopedia of Medical and Dental Materials. Elmsford NY: Pergamon Press; 1990:74-85."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(85)90615-1"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)50700-6"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820180503"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)34385-5"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/026765919000500406"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/1010-7940(90)90047-4"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/026765919100600310"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.7.3198"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(00)81050-2"},{"key":"e_1_3_1_25_2","first-page":"3","volume":"28","year":"1991","unstructured":"Pratt CW, Church FC. Antithrombin: structure and function. Semin Hematol. 1991;28:3-9.","journal-title":"Semin Hematol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/08941939109141159"},{"key":"e_1_3_1_27_2","first-page":"1","volume":"15","year":"1969","unstructured":"Grode GA, Anderson SJ, Grotta HM, Falb RDD. Nonthrombogenic material via a simple coating process. Trans Am Soc Artif Intern Organs. 1969;15:1-5.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_3_1_28_2","first-page":"1888","volume":"19","year":"1973","unstructured":"Tanzawa H, Mori Y, Harumiyua N, Miyama H, Hori M. Preparation and evaluation of a new antithrombogenic heparinized hydrophyllic polymer for use in cardiovascular systems. Trans Am Soc Artif Intern Organs. 1973;19:1888-1894.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_3_1_29_2","unstructured":"Jozefowicz M Jozefowicz J. Heparin-containing and heparin-like polymers. In: Chiellini E Giusti P eds. Polymers in Medicine. New York NY: Plenum Press; 1983."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820110212"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820110210"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820190407"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/10731198309118804"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6215(83)88103-8"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109661"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb33034.x"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.1810310209"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.1810350102"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.6.1676"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Hass WK Easton JD. Ticlopidine Platelets and Vascular Disease. New York NY: Springer-Verlag; 1993.","DOI":"10.1007\/978-1-4613-8306-2"},{"key":"e_1_3_1_41_2","unstructured":"Gawaz M Neumann F Ott I May A Sch\u00f6mig A. Platelet activation and coronary stent implantation: effect of antithrombotic therapy. Circulation. In press."},{"key":"e_1_3_1_42_2","unstructured":"Gregorini L Marco J Fajadet J Brunnel P Cassagneau B Bossi I. Ticlopidine attenuates post-angioplasty thrombin generation. Circulation. 1995;92(suppl I):I-608. Abstract."},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.3.8087933"},{"key":"e_1_3_1_44_2","unstructured":"Palmaz-Schatz balloon-expandable stent and delivery system: PMA 900043 Panel Package: Circulatory System Devices Panel: May 3 1994: Division of Cardiovascular Respiratory and Neurological Devices: US Food and Drug Administration."},{"key":"e_1_3_1_45_2","unstructured":"Lincoff AM Van der Giessen WJ Schwarz RS Van Beusekom HMM Serruys PW Holmes DR Ellis SG Topol EJ. Biodegradable and biostable polymers may both cause vigorous inflammatory responses when implanted in the porcine coronary artery. J Am Coll Cardiol. 1993;21(suppl A):179A. Abstract."},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80384-3"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.93.3.412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T15:32:33Z","timestamp":1715527953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.93.3.412"}},"subtitle":["Early Outcome of the Benestent-II Pilot Study"],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1161\/01.CIR.93.3.412"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.93.3.412","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]},"assertion":[{"value":"1995-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}